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Summary 
The secretion of specific antibodies and the development of somatically mutated memory B cells 
in germinal centers are consequences of T cell-dependent challenge with the hapten (4-hydroxy- 
3-nitrophenyl)acetyl (NP). Using six-parameter flow cytometry and single cell molecular analysis 
we can directly monitor the extent of somatic hypermutation in individual responsive (isotype 
switched) antigen-specific  B cells. The current study provides a direct quantitative assessment 
of recruitment into the antibody-secreting compartment on the one hand, and the germinal 
center pathway to memory on the other. Cellular expansion in both compartments is exponential 
and independent during the first week after challenge.  The first evidence of somatic mutation, 
towards the end of the first week, was restricted to the germinal center pathway. Furthermore, 
germinal center cells express a significantly shorter third hypervariable  region (CDR3),  even 
when unmutated, than their antibody-secreting counterparts, suggesting a secondary selection 
event may occur at the bifurcation of these two pathways  in vivo. By the end of the second 
week, the majority of mutated clones express a shorter CDR3 and affinity-increasing  mutations 
as evidence of further selection after somatic mutation. These data provide evidence for substantial 
proliferation within germinal centers before the initiation of somatic mutation and the subsequent 
selection  of a significant  frequency of mutated clonotypes into the memory compartment. 
S 
ecretion of specific antibody by plasmacytes and the de- 
velopment of germinal centers  is an early response to 
T cell-dependent immunization. After immunization, early 
B cell blast development is apparent in the periarteriolar lym- 
phoid sheaths (PALS)  1 in T cell zones of the spleen and pro- 
duce loci of short-lived plasmacytes (1-4).  In contrast, early 
proliferation seen within the follicular B cell regions creates 
a secondary lymphoid follicle which subsequently differen- 
tiates into a germinal center with histologically distinct light 
and dark zones (5-7). The complex microenvironment of the 
germinal center reaction is the proposed site of memory cell 
differentiation. Germinal center B cells are thought to ran- 
domly diversify their Ig genes by a process of somatic hyper- 
mutation after  which high affinity  variants  are selectively 
preserved as memory cells for response to secondary antigenic 
challenge (6, 8-15).  The mechanisms that initiate or control 
1 Abbreviations  used in this paper: APC, allophycocyanin; NP, (4-hydroxy- 
3-nitrophenyl)acetyl;  PALS, perarteriolar lymphoid sheaths; PNA, peanut 
agglutinin, TR-av, Texas red-avidin. 
The DNA sequence information for all PCR products in this study is 
available  from  EMBL/GenBank/DDJB  under  accession  number 
L16689-L16763. 
these complex differentiative responses to primary antigenic 
challenge remain elusive. 
The response of C57BL/6 mice to the hapten (4-hydroxy- 
3-nitrophenyl)acetyl (NP) has been well characterized at both 
the molecular and cellular level (16-18). B cell clones expressing 
antibodies using the V.186.2 H and VM L chain combina- 
tion dominate the early primary NP response (19, 20). There 
is evidence for somatic mutation in these clonotypes as early 
as day 6 after primary NP immunization (21, 22). Further- 
more, a mutational change in the CDR1 resulting in a tryp- 
tophan to leucine change at amino acid position 33 can lead 
to a 10-fold increase in affinity for NP (23). The change in 
position 33 is found in about 75% of late primary and memory 
clones and provides a good molecular marker of selection post- 
somatic mutation  (24,  25).  Using immunohistochemical 
methods, subsequent regional microdissection and molecular 
analyses, Jacob et al. (3, 12, 26) have analyzed both extrafol- 
licular and germinal center pathways  of NP-specific B cell 
development in vivo. These workers outline the magnitude 
and kinetics of the cellular response and identify the process 
of somatic mutation in only the germinal center pathway. 
Using six-parameter  flow cytometry, we can isolate  in- 
dividual IgG1 + NP-specific memory B cells after secondary 
challenge with NP (25) and IgG1 + NP-specific B cells from 
the primary response (27). Furthermore, the surface expres- 
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defines antibody-secreting cells in vivo (27), whereas the lectin 
peanut agglutinin (PNA) selectively binds to high levels on 
germinal center cells (30). In the current study, syndecan ex- 
pression and PNA binding define the independent develop- 
ment of early antibody secreting and germinal center cells 
within  the  antigen-specific compartment  of a primary re- 
sponse. Single cell molecular analysis allows direct assessment 
of the mutational status within individual members from each 
of these pathways. The results confirm the early onset of so- 
matic mutation to the end of the first week after challenge 
(22) and support the restriction of somatic mutation to the 
germinal center pathway of development (11, 12). The data 
also provide evidence of substantial proliferation in the ger- 
minal center before initiation of somatic mutation. Further, 
the pattern of CDR 3 usage in germinal centers versus anti- 
body-secreting cells suggests that a secondary selection event 
may occur at the bifurcation of these pathways in vivo. Fi- 
nally, a significant frequency of mutated clones bearing affinity- 
increasing mutations emerges by the end of the second week 
as evidence of further  selection after somatic mutation. 
Materials and Methods 
Immunization, Spleen Cell Suspensions, and FACS  ~ Staining.  8-10- 
wk-old specific  pathogen-free, male and female C57B1/6 mice were 
immunized with 200 ~tg of alum-adsorbed NP-KLH together with 
109 inactivated Bordetella pertussis by intraperitoneal injection. Mice 
were killed and spleens removed on the stated days after immuniza- 
tion and processed individually with erythrocytes and dead cells 
removed as previously described (31). Spleen cells were stained on 
ice for 20 min with biotin goat anti-IgG1 (Southern Biotechnology 
Associates, Birmingham, AL) washed, and resuspended in 50 #g/m1 
of purified MOPC245T (an IgG1 myeloma) as a blocking reagent 
followed by costaining with Texas red-avidin (TR-av), NP and NIP 
(4-hydroxy-5-iodo-3-nitrophenyl)acetyl-coupled  allophycocyanin 
(NP/NIP-APC),  PE conjugates of 331.12 (anti-IgM),  8C5 (anti- 
GR1) and M1/70 (anti-MAC1/CDllb) (331.12/8C5/M1/70-PE), 
and fluoresceinated JC5 (anti-X L chain; kindly provided by Dr. 
L. A. Herzenberg, Stanford University, Stanford, CA) or fluorescei- 
nated PNA (Vector Laboratories Inc., Burlingame, CA). Alterna- 
tively, cells were stained with fluoresceinated anti-IgG1 (Southern 
Biotechnology Associates), blocked with MOPC245T, and stained 
with biotin-281.2 (anti-syndecan; 28), washed, and costained with 
TR-av,  NP/NIP-APC,  and  331.12/8C5/M1/70-PE.  Ceils  were 
finally resuspended in propidium iodide (1 #g/ml), analyzed by use 
of a FACStar Plus  |  (Becton Dickinson  & Co., Mountain  View, 
CA), and sorted using an automated cell deposition unit.  All re- 
agents and staining procedures have been described in more detail 
previously (27). 
In Vitro Culture and Assay.for Specific Antibody.  Single  cells were 
sorted directly into 200-/zl 96-well microtiter  plates with 2,500 
BALB/c 3T3 fibrobhsts per well, 40/zg/ml ofEscherichia coli 011:B4 
LPS (Difco Laboratories Inc., Detroit, MI), 50 U/ml rib4 (kindly 
provided by Dr. S. Gerondakis, Walter and Eliza Hall Institute), 
20 U/ml rib2 (Perkin Elmer Cetus Corp,  Emeryville, CA), and 
2% rlb5-containing supernatant (vol/vol) for 8 d at 37~  in 10% 
CO2 and air  (32). ELISA for detection  of total  IgG1  and NP- 
specific IgG1 were performed  as previously described (33, 34). 
Briefly, flexible U-bottomed 96-well plates (Dynatech Laborato- 
ties, Inc., Chantilly, VA) were coated overnight with 50/xl/well 
of either sheep anti-mouse Ig (4/~g/ml; Silenus Laboratories, Md- 
bourne, Australia) or NP-BSA conjugate (25 mg/ml), washed, and 
samples added in PBS with 0.1% Tween 20, 0.3% (wt/vol) skim 
milk powder, and 1% newborn calf serum, held at room tempera- 
ture for at least 4 h, washed before the addition of 50/~l/well horse- 
radish peroxidase conjugates of sheep anti-mouse IgG1 (Silenus 
Laboratories), and held again overnight at room temperature be- 
fore washing and the addition of 100 #l/well of enzyme substrate 
2,2'-azinobis(3-ethylbenzthiazoline) (Sigma Chemical Co., St. Louis, 
MO) at 0.55 mg/ml in 0.1 M sodium citrate, pH 4.5, and 0.1% 
H202. Absorbance was read 1 h later at 414 nm (reference wave- 
length 492 nm) on a Titertek Multiscan (MCC/340; Flow Labora- 
tories, McLean, VA). 
Clonal  VH Gene  Analysis,  Individual  cells with  the desired 
phenotype were sorted directly using the automatic cell deposition 
unit on the FACStar Plus  |  as two or four cells per well into 96- 
well microtiter  plates containing  10/xg of carrier E. coli tRNA 
(Boehringer Mannheim Corp., Indianapolis, IN) and 200/zl/well 
of a protein denaturating  solution (4 M guanidine thiocyanate, 25 
mM sodium citrate, pH 7, 0.2% sarcosyl, 0.2 M 2-ME) followed 
by an acid phenol-chloroform extraction and ethanol precipitation 
of the RNA as described (35). First strand cDNA was synthesized 
from one fifth of each sample using  AMV reverse transcriptase 
(Promega,  Madison,  WI) with  oligo  dT priming  (Boehringer 
Mannheim Corp.) in standard reaction conditions. One quarter of 
the cDNA mixture was processed through  two separate sets of 
the PCR (36) using ampli-Taq (1 U/30/zl reaction) (Perkin Elmer 
Cetus Corp.) in standard buffer containing 2 mM MgC12, 0.2 mM 
mixed dNTPs and 1/~M oligomer primers. First set primers were 
GGATGACTCATCCCAGGGTCACCATGGAGT for Ch~/1 and 
GCTGTATCATGCTCT'I~TTG  for V.186.2 with the second set 
"nested" medially with CCA~CAGTGGATAGAC  for Ch~/1 
and GGTGTCCACTCCCAGGTCCA  for V,186.2. 35 cycles  were 
performed with melting at 94~  for 45 s, annealing at 550C for 
60 s and elongation  at 72~  for 90 s, 5 ml of a 1/500 dilution 
of the first round PCR reaction mixture was used as DNA source 
for 35 cycles of the second round using identical conditions.  The 
PCR products were purified by low melt agarose gel electropho- 
resis and isolated by phenol/chloroform extraction. DNA sequencing 
was performed by the dideoxy chain termination method (37) with 
modifications for double stranded DNA template as described (38) 
using the same primers as the second set for PCR. Positive samples 
that contained more than one species of DNA (from starting cell 
numbers of two and four this was a possibility) were readily dis- 
cernible by two distinct lengths  of template (resolvable to single 
base differences) and smearing through CDR 3 on the autoradio- 
graphs, in these infrequent cases (<1/8 for 281 + and )x +, <1/20 
for  the PNA +) the sequence was not included  in the analysis. 
When two sequences were identical through the CDR 3 and were 
unmutated,  only one sample was reported because of the inability 
to verify the origins as independent  events. 
Results 
The Emergence of NP-specific B Cells In Vivo.  We directly 
monitored  the  emergence  of NP-specific B  cells that  had 
switched  to  IgG1  surface  isotype in  response  to  T  cell- 
dependent immunization with NP. Fig. 1 A  clearly demon- 
strates the specificity of the reagents used in the FACS  |  anal- 
ysis of the  NP response.  The  population  of (IgM;  Mac1: 
GR1)-  IgGI+X+NP + cells  only emerges after immuniza- 
tion with NP-KLH and is absent with carrier only (Fig.  1 
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Figure  1.  Antigen-binding  B 
cells in the primary response to NP- 
KLH. (A) X L chain expression and 
NP/NIP binding for gated popula- 
tions  of  (IgM;  Mac1; GR1) 
IgG1 +  spleen cells from  animals 
7 d after immunization  with either 
KLH only or NP-KLH as indicated. 
5%  probability  contour plots  are 
shown. (B) (~p) NP/NIP binding 
vs X L chain expression on spleen 
cells from individual animals  selected 
as  (IgM;  Mac1; GR1)-  IgG1 + 
NP +.  Headings  represent  time 
after immunization  with NP-KLH. 
The  number in  the  upper  right 
corner of each panel represents the 
frequency of (IgM;  Macl;  GR1)- 
IgG1 + NP + that were also X  + per 
105 total viable spleen cells. (Inset) 
The boundaries of a subpopulation 
referred to in the text as X2+Np  2+ 
and the number within refers to 
their frequency per 10  s total viable 
spleen cells. (Bottom) Small forward 
light scatter (IgM;  Mac1; GR1)* 
IgG1- cells and background level 
of staining for the two markers on 
the  majority  of  resting  B  cells. 
2--4% of resting B cells  express 4-25 
fluorescence U  of X L chain but 
cannot be seen in this display. All 
plots  are 10% probability  density 
contours.  (C)  The  frequency  of 
(IgM; Mac1; GR1)- IgG1 + NP § 
X  + cells in the spleens of individual 
animals either  naive (DO) or after 
intraperitoneal immunization  with 
200 mg NP-KLH. At least 100,000 
events were collected for each fie- 
quency estimation (500,000 for the 
DO time point). 
A).  Furthermore,  the population  of NP-binding  cells was 
negative for staining with an anti-K L chain antibody (187.1). 
The majority (>90%) of (IgM; Mac1; GR1)-IgG1 § NP + B 
cells expressed the X L chain (Fig.  1 B). The population of 
small resting B cells displays the level of background staining 
for the NP and anti-X reagents demonstrating  a reassuring 
signal to noise ratio  at all stages of the response.  Between 
2 and 4% of the resting B cells display 4-25 fluorescence units 
of binding to the anti-X reagent, but cannot be seen on the 
contour representation in Fig.  1 B. Interestingly,  a popula- 
tion  of cells binding  higher  levels of NP (>15  U) and ex- 
pressing  higher  levels  of ;k  (>25  U)  (NP  2+  ;k  2+)  emerges 
over time to comprise up to 60% of the total IgG1 +-specific 
B cell population  by day 14. 
During the  first  week  of the  primary response,  the  fie- 
quency of X + isotype-switched antigen-specific cells expands 
exponentially after a 2-3 d lag phase (Fig. 1 C). The 100-fold 
increase in cell numbers between days 4  and 7  corresponds 
to an approximate  10-h doubling time of cell accumulation 
within  this  compartment.  The  extent  of  the  response  is 
remarkable, reaching 1,900  +  330 (_+  SEM,  n  =  6) per 10  s 
spleen cells at its peak  on days  7-8.  The frequency of NP- 
specific cells remains  ~1%  of total  splenocytes during the 
second week.  There is evidence of cell death in vivo during 
297  McHeyzer-Williams et al. this latter phase (6), suggesting that proliferation and death 
appear balanced during this second week of the primary NP 
response. 
The Onset of Somatic Mutation in Responding NP-specific B 
Cells.  We next assessed the level of point mutation in the 
VH186.2 genes  of individual cells  sorted  according  to  the 
unique phenotype described above. To obtain enough DNA 
to sequence directly without subcloning, we needed to sub- 
ject newly synthesized cDNA to two separate sets of 35 cycles 
of PCR.  50% of single micromanipulated  hybridoma cells 
produced enough DNA for sequence analysis that remained 
faithful to the expected  germline sequence in 10 out of 10 
separate cases. With independent PCR products  sequenced 
in both directions, this represents a background of <1/6,000 
introduced errors "seen" by this method. The lack of back- 
ground is further evidenced in Fig. 2. None of the 18 unique 
NP-specific  cells  bearing  V.186.2  sequence  contained evi- 
dence of mutation (<1/10,000 bp).  This approach renders 
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Y  Y  Y  G  S  N  Y  F  D  Y 
TAT  TAC  TAC  GGT  AG  C  AAC  TAC  TTT  GAC  TAC 
Y  Y  G  S  R  Y  D  Y 
TAC  TAC  GGT  TCG  CGC  TAT  GAC  TAC 
Y  Y  Y  G  S  S  Y  F  D  Y 
TAT  TAC  TAC  GGT  AGT  AGC  TAC  TTT  GAC  TAC 
Y  Y  Y  G  S  T  Y  Y  F  D  Y 
TAT  TAC  TAC  GGT  AGT  A  CC  TAC  TAC  TTT  GAC  TAC 
Y  D  Y  G  Y  D  S  A  W  F  A  Y 
TAC  GAC  TAT  GGT  TAC  GAC  TCG  GCC  TGG  TTT  GCT  TAC 
YyY  PRSY 
1  ......  TATTACTAC  CCTA~AGTTAC 
YyY  DSRWYY 
2  --G  TAT  TAC  TAC  GAT  AGT  AGG  T~  TAC  TAC 
YKG  YFDY 
3  T  TAC  ~G  GGG  TAC  TTT  GAC  TAC 
GNYPY  YFDY 
￿9  G  GGT  ~C  TAC  CCA  TAC  TAC  TTT  GAC  TAC 
$  -T--G-  -A-  TACGGATGGG~TATGCT  ATGGCTTAC 
YVRGN  YFDY 
TACGTTAGGGGT~C  TACTTTGACTAC 
YyYGSS  YFD 
7  TAT  TAC  TAC  GGT  AGT  AGC  TAC  TTT  GAC 
[]  S  YYGSS  HFD 
G  GGT  TAC  TAC  GGT  AGT  &GC  CAC  TTT  GAC  | 
~  NA  YYYGSS  LFDY 
g  -A-  -T-  GCT  TAT  TAC  TAC  GGY  AGT  AGC  CTC  TYT  GAC  TAC 
T  YYYGSS  LFDY 
10  -CT  TAT  TAC  TAC  GGT  AGT  AGC  CTC  TTT  GCT  TAC 
T  u  YFDY 
--T  TAT  TAC  TAC  GGT  AGT  A~  TAC  TTT  GAC  TAC  11 
]  YYYGSS  TFDY 
G  TAT  TAC  TAC  GGT  AGT  AGC  ACC  TTT  GAC  TAC 
YyyGssY  YFDY 
U  "--  TAT  TAC  TAC  GGT  AGT  A~  TAC  TAC  TTT  GAC  TAC 
YS  YYGSS  YFDY 
14  TAC  TCT  TAC  TAC  GGT  AGT  AGC  TAC  TTT  GAC  TAC 
SYPYyYGSS  YFDY 
15  TAC  CCT  TAT  TAC  TAC  GGT  AGT  A~  TAC  TTT  GAC  TAC 
ypFYYGSS  YFDY 
16  TAC  CCC  TT  T  TAC  TAC  GGT  AGT  A~  TAC  TTT  GAC  TAC 
IS  yYGSSY  YFDY 
17  ATC  TC  T  TAC  TAC  GGT  AGT  AGC  TAC  TAC  TTT  GAC  TAC 
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Figure  2.  Onset of mutation in the primary NP response. The nucleotide sequence and predicted amino acid obtained from individual (IgM; Mac1; 
GR1)-  IgG1 + NP + k + cells sorted directly from the spleens of animals 6 and 7 d after primary immunization with NP-KLH.  The sequences are 
compared to the germline sequence of V,186.2 displaying only those positions  in which changes were seen (numbering according to reference 57). 
Where obtained,  sequence to the fourth codon in the J, region  is displayed and the predicted size of CDP,3 is listed in the last column. (Dashes) 
Identity with the germline sequence, where possible J, assignment  is included in parentheses at the end of each sequence.  (*) DFL16.1  not used. 
298  Antigen-driven B Cell Differentiation the system operationally free of background.  Whereas  the 
introduced  Taq polymerase error  is not  ablated,  the detec- 
tion of molecules containing  these errors is limited because 
of the relative inefhciency of direct double stranded DNA 
sequencing. The efficiency of producing sufficient DNA for 
direct sequence analysis after immediate ex vivo purification 
RNA extraction, cDNA synthesis, and two separate rounds 
of PCR was 12 and 20% for day 6- and day 7-specific cells, 
respectively (Fig.  2). 
Using this approach,  we are able to analyze DNA sequences 
from individual cells that are expressing the k L chain, have 
isotype switched in response to antigen, and are able to bind 
NP. All IgM-  IgG1 + k + NP-binding cells isolated from day 
6 of the primary response expressed unmutated  V.186.2 H 
chain genes (Fig.  2).  By day 7, 30% of NP-specific cells ex- 
pressed a somatically varied V.186.2  gene with  an average 
of 1.6 mutations per V. gene and a 1:7 silent to replacement 
ratio. A characteristically retained tyrosine at position 95 on 
the VH-D border was found in 24 out of 27 NP-specific cells 
from this early stage of the primary response. An intact GSS 
motif at  the D-J. border was expressed by only 13 of the 
27 cells,  and evidence of N  sequence insertion  at either the 
V.-D  or D-J. border was present  in all but two cells  ana- 
lyzed. The average number of amino acids in CDR 3 from 
responders at this early phase of the response was 9.9  _+ 0.27 
(_  SEM;  n  =  25). Joining region J,2 was expressed in 22 
out of 25 cells assigned and the DFL16.1 in 22 of 27 cells. 
Together with the direct frequency estimate of NP-specific 
cells, 0.3-0.9%  of total cells in the spleen would have initi- 
ated a process of somatic mutation known to proceed in the 
germinal  center environment  of the primary response (12, 
26). At this early stage of the response, the majority (70%) 
of NP-specific responders remain unmutated.  This could be 
due to their location in the PALS-associated loci as unmu- 
tated antibody-forming cells (3, 26) or their presence in ger- 
minal  centers in  an unmutated  form. 
The Emergence of Antigen-specific Antibody-secreting  Cells In 
Vivo.  We have recently defined surface expression of syn- 
decan as a sensitive marker of antibody-secreting cells (27), 
and therefore can purify NP-specific cells in this phenotypi- 
cally and functionally distinct developmental pathway. Syn- 
decan-expressing,  antigen-specific,  isotype-switched B cells 
are a subset of cells whose primary response to antigenic chal- 
lenge is the production of non-IgM antibody. Fig. 3 A  out- 
lines a representative series of FACS |  profiles depicting the 
emergence of syndecan + cells within the IgM  NP-binding 
compartment of the spleen during a primary response to NP- 
KLH. The small IgM+NP -  cells serve to display the back- 
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Figure  3.  Antibody-secreting B 
cells in the primary response to NP- 
KLH.  (A) (~p) Syndecan vs IgG1 
expression on spleen cells from in- 
dividual animals selected as (IgM; 
Mac1; GRI)-  NP + . Headings rep- 
resent time after immunization with 
NP-KLH. The number in the upper 
right corner of each panel represents 
the  frequency  of  (IgM;  Mac1; 
GR1)  IgG1 + NP + that were also 
syndecan  expressing  per  10 s  total 
viable spleen cells.  (Bottom) Small 
forward light scatter (IgM;  Mac1; 
GR1) +  NP  cells  and  represent 
the background level of staining for 
the two markers on the majority of 
resting B  cells.  All plots are  10% 
probability  density  contours.  (B) 
The  frequency  of  (IgM;  Mac1; 
GR1)  IgG1 + NP + 281.2 + cellsin 
the spleens of individual animals ei- 
ther naive (DO)  or after intraperi- 
toneal immunization with 200 ~g 
NP-KLH.  Boundaries for fluores- 
cence intensities used for frequency 
estimates are displayed in Figs.  1 and 
3 A.  At least 100,000 events were 
collected for each frequency estima- 
tion  (500,000  for  the  DO  time 
point). ground staining for syndecan. The phenotype profile of the 
NP-binding cells also identifies a sizable non-IgM, non-IgG1 
component in these animals, both secreting and nonsecreting 
(Fig.  3 A). This fraction of the response appears before the 
IgG1 component and can remain sizable up to 10 d after ini- 
tial antigen exposure.  Other IgG isotypes could contribute 
to this subset with clones that have switched to isotypes down- 
stream of IgG1 appearing later. There is still a need for detailed 
analyses of this unique and heterogeneous subset. 
Emergence  of the NP-specific IgG1 + secreting  compart- 
ment parallels of the total  isotype-switched compartment. 
A lag phase of 3-4 d precedes an exponential rise that peaks 
on days 7-8 and declines noticeably thereafter (Fig. 3 B). A 
500-fold  increase  in  cell  numbers between  days 4  and  7 
represents an approximate doubling time of 8 h for this popu- 
lation at the proliferative phase of the response. At its height, 
the NP-specific secreting  population comprises  720  _+  180 
(+_  SEM; n  --  6) cells  per  l0  s spleen cells  that  represents 
approximately  one third of the total  NP-specific compart- 
ment. Furthermore, by day 10 of the primary response 75-90% 
of these cells are lost. The rapid decline in cell numbers may 
be due to the short life span of these cells, consistent with 
the 3-5-d life span of the short-lived plasmacyte of the PALS- 
associated loci (4). Alternatively, the syndecan + cells may be 
rapidly exported from the spleen at the later stage of the re- 
sponse.  In either case, syndecan expression  defines the pri- 
mary response B cell as one that  secretes antibody as a re- 
sponse to initial encounter with antigen. 
Early Antibody-secreting Cells Remain Unmutated.  Next, 
we assessed the mutational status of the antigen-specific cells 
in this primary response B cell compartment. Single cells from 
the early primary antibody-secreting pathway were purified 
by six-parameter flow cytometry for molecular  analyses of 
their V.186.2 genes as described.  On average, 36% of cells 
sorted immediately ex vivo produced sufficient DNA for di- 
rect sequence analysis after RNA extraction, cDNA synthesis, 
and two separate cycles of PCR. Fig. 4 displays a pand of 
sequences from antibody-secreting  cells at the end of the first 
week after primary immunization. All 18 members express 
an unmutated V.186.2 H chain gene. Of the 15 V gene se- 
quenced through to the J., 13 retained the tyrosine at posi- 
tion 95. Only 6 out of the 15 expressed an intact GSS motif 
at the D-J. border, previously though to be characteristic of 
the early primary NP response (39). Furthermore, all 11 ceils 
expressing  the DFL16.1 diversity element showed evidence 
of N  sequence insertion on either the V.-D or D-J, borders, 
unlike the typical unmutated primary NP hybridomas. Usage 
of J.2 dominated with only three ceils using J,4. The length 
of CDR3 varied from 8 to 13 amino acids with an average 
length of 10.4  _  0.37 (__. SEM; n  =  15). 
Overall, the syndecan + antigen-specific compartment  cor- 
relates well with the PALS-associated foci regarding  func- 
tion and mutational status  (3,  26).  Direct in situ staining 
is yet to be done with the anti-syndecan  reagent.  Further- 
more,  the profile  of CDR  3  diversity  appears somewhat 
different from what was seen in the primary response  NP 
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Figure  4.  Antibody-secreting  cells of the early primary response remain unmutated. The nucleotide sequence and predicted amino acid assignment 
obtained from individual cells with the phenotype of antibody-secreting cells from days 6 and 7 as described. The sequences are compared to the germline 
sequence of V.186.2 displaying only those positions in which changes were seen. Where obtained,  sequence to the fourth codon in the J. region is 
displayed and the predicted size of CDR3 is listed in the last column. (Dashes) Identity with the germline sequence, where possible J. assignment 
is included in parentheses at the end of each sequence. (*) DFL16.1  not used. 
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Figure 5.  The  early  antibody- 
secreting and germinal  center  are 
separate pathways of development. 
(A) The syndecan and (IgM; Mac1; 
GR1) levels on IgG1 + cells in the 
spleen of animals 7 d after immuni- 
zation.  Cells were costained with 
biotin-anti-IgG1 followed by TR- 
avidin, fluoresceinated PNA, APC- 
281.2, and PE-331.12/8C5/M1/70 
and resuspended in PI before anal- 
ysis.  (Top inset)  The  boundaries 
chosen  to  signify cells as  IgG1 + 
(IgM;  Macl;  GR1)-  syndecan + 
cells within the spleen; (bottom inset) 
IgG1 §  (IgM;  Mac1;  GR1) 
syndecan- cells. (B) PNA binding 
vs. forward light scatter (as an index 
of  cell size) of  isotype-switched 
antibody-secreting  cells (syndecan  +); 
(top)  and  isotype-switched  non- 
secreting cells (syndecan-); (bottom) 
in the early primary response (days 
6 and 7 after immunization). All 
plots  are 10% probability  density 
contours. 
hybridomas and may reflect the different selection bias im- 
posed by the fusion procedure. 
The Emergence of  Antigen-specific Germinal Center Cells.  In 
contrast to the antibody-secreting effector arm of the pri- 
mary response,  there is a subset of antigen-activated B cells 
that proceeds through the germinal center pathway of devel- 
opment after antigenic challenge. The binding of a lectin, 
PNA, in tissue section identifies these germinal center cells 
(30).  Whereas cells in the antibody-secreting pathway bind 
higher levels of PNA than small resting lymphocytes, the 
IgM  IgG1 + syndecan- subset of cells binds still 2-10-fold 
higher PNA levels (Fig.  5).  This is also true for the IgM- 
NP + cellular subset where syndecan- cells bind higher levels 
of PNA than the syndecan  + ones (data not shown). 
Previously, using a sensitive Elispot assay for detecting the 
secreted antibody of individual cells,  we demonstrate that 
>90%  of specific IgG1 + syndecan  + cells of the early pri- 
mary response secrete antibody in vitro with no stimulus (27). 
In contrast, <2%  of the syndecan- component of this re- 
sponse were capable of secretion. In the current study, we 
use an in vitro cloning system to assess the ability of individual 
antigen-specific cells to form clones that are capable of secreting 
>1  ng of antibody over the 8-d culture period  (Table  1). 
Greater than 90%  of the responding clones from the k+ 
population secreted antibody with the isotype and specificity 
predicted from its phenotype (Table 1). The sorting purity 
and cloning efficiency were comparable to that achieved with 
the early secondary response (25). At this early stage of the 
in  vivo  response,  it  was  the  syndecan +  component  that 
responded to culture (Table  1).  Whereas only 15%  of the 
syndecan  §  cells  were capable  of producing  over  1  ng  of 
specific  IgG1,  90%  of these clones secreted the predicted 
specificity and isotype. On the other hand, the syndecan- 
compartment  (the  majority of which  are  PNA hi)  largely 
Table  1.  In  Vitro  Response from  Isotype-switched  Antigen-binding  Primary B  Cells 
Phenotype 
Number of positwe clones per  1,000 input cells 
Experiment  1  Experiment 2 
Total IgG1  Anti-NP IgG1  Total IgG1  Anti-NP IgG1 
(IgM,  Mac1,  GR1)-NP+X+IgG1 + 
(IgM,  Mac 1,  GR 1) - NP - )x +  syndecan  + 
(IgM,  Mac1,  GR1)-NP +  X +  syndecan 
170  170  140  130 
150  140  130  120 
35  20  25  10 
Filler cell-supported  cultures in the presence of LPS, rlL-2,  rlL-4, and rlL-5 as described. Frequencies were calculated from data for 300-1,000 cells 
of each selected population directly deposited into individual wells of a 96-well microculture  plate using the automatic  cell dispensing unit on the 
FACStar Plus  |  Supernatants were  assayed at day 8 of culture to determine  isotype and specificity by ELISA. 
301  McHeyzer-Williams et al. failed to form antibody after stimulation  in culture.  These 
data further  support the classification of these cells  as ger- 
minal center cells known to die rapidly in vitro without the 
appropriate accessory cell support or costimulation (14, 40). 
By using very high levels of PNA binding  (>20 fluores- 
cence units) the emergence of isotype-switched antigen-specific 
germinal center cells can be monitored.  Fig. 6 A  displays  a 
typical series of FACS  |  profiles used to discriminate the popu- 
lation of large forward scatter (an index of a cell's cross-sectional 
area) germinal center cells. By day 12, many of the cells are 
smaller again (Fig.  6 A). The intermediate staining of PNA 
by the syndecan § cells can also be seen on these plots, and 
in general these cells are slightly larger than their germinal 
center counterparts.  Low PNA staining  and forward light 
scatter typical of the resting IgM + IgG1- NP + changes only 
minimally  over the immunization  period  (Fig.  6 A). 
The direct frequency analysis  displayed in Fig.  6 B indi- 
cates the emergence of isotype-switched, antigen-binding ger- 
minal center cells during the primary response to NP-KLH. 
The kinetics are remarkably similar to those for the antibody- 
secreting compartment.  A  2-3 d lag period is followed by 
an  exponential  growth phase reaching  a peak at days 7-8. 
This population increase represents an approximate doubling 
time of 10 h at this proliferative phase of the response.  At 
its height,  this population comprises 810  _+  130 (_+  SEM; 
n  =  6) cells per  10  s spleen cells  and is very similar  to the 
extent of the syndecan + population.  Unlike the latter sub- 
set,  the germinal  center cells persist at a plateau frequency 
for the duration of the second week. This plateau may repre- 
sent the selection phase of the response where proliferation 
of positively selected cells balances the extensive cell death 
seen in  the  germinal  centers  (14,  41,  42). 
Early Germinal Center Cells Express an Unmutated V,186.2 
Gene with a Short CDR 3.  Next, we assessed the mutational 
status  of the  antigen-specific  cells  in  this  germinal  center 
pathway  to  memory  cell  differentiation.  Single  isotype- 
switched NP-binding B cells that bound high levels of PNA 
(>20 U) were purified by six-parameter flow cytometry for 
molecular analyses  of their V.186.2 genes as described. On 
average,  8%  of cells  sorted immediately ex vivo produced 
sufficient DNA for direct sequence analysis  after RNA ex- 
traction,  cDNA synthesis, and two separate cycles of PCR. 
We believe the process efficiency relates to the reduced amount 
of V gene mRNA present in germinal center cells compared 
with antibody-secreting cells as seen by in situ hybridization 
(3). Whereas carrier tRNA is essential to reduce loss of specific 
mRNA at the extraction step,  cDNA synthesis is the most 
inefficient  process of the preparative  phase. 
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Figure  6.  Germinal  center  B 
cells in the primary response to NP- 
KLH.  (A)  (%p) PNA binding vs 
forward light scatter on spleen cells 
from individual animals selected as 
(IgM; MacI; GR1)-  IgG1 § NP +. 
Headings represent time after im- 
munization  with  NP-KLH.  The 
number in the upper right corner 
of each  panel  represents  the  fre- 
quency  of  (IgM;  Mac1;  GR1)- 
IgG1 + NP + that also display high 
levels of PNA binding per 105 total 
viable spleen cells.  (Bottom)  (IgM; 
Mac1;  GR1) +  IgG1-  NP-  cells 
and represent the background profile 
on the majority of resting B cells. 
All plots are 10% probability den- 
sity contours. (B) The frequency of 
(IgM; Macl; GR1)  IgG1 + NP + 
PNA  hi cells  in  the  spleens of in- 
dividual animals either naive (DO) 
or after intraperitoneal immuniza- 
tion  with  200  mg  NP-KLH. 
Boundaries for fluorescence inten- 
sities used for frequency estimates 
are displayed in Figs. I and 4 A. At 
least 100,000  events were collected 
for  each  frequency  estimation 
(500,000  for the DO time point). 
302  Antigen-driven B Cell Differentiation Fig. 7 displays the V.186.2 sequence from a panel of ger- 
minal center cells from the end of the first week after pri- 
mary immunization. Only 2 of the 14 cells analyzed expressed 
a mutated H chain gene.  It must be emphasized that these 
cells have already switched Ig isotype to IgG1 and are also 
able to bind antigen. By correlation with immunohistochem- 
ical analyses, these cells would most closely correspond to 
slg + centrocytes, the cells emergent from the slg  l~ early B 
cell blast (or later centroblast) phase of the germinal center 
reaction (3, 43). Therefore, the earliest products of the ger- 
minal center reaction appear largely unmutated. 
The tyrosine at position 95 was retained by 10 of the 14 
cells analyzed implicating  the importance of this residue to 
NP binding even in this differentiation pathway. Only three 
of the cells expressed an intact GSS motif at the D-J. border, 
a similar pattern to that seen in the antibody-secreting com- 
partment. Furthermore, of the nine cells using the DFL16.1 
diversity element,  eight displayed N  sequence insertions at 
either the V.-D or D-J. borders in a similar pattern to the 
antibody-secreting cells. It was the length of the CDR 3 re- 
gion that appeared most strikingly different between the two 
functionally  distinct populations.  Of the 12 cells character- 
ized through to J. assignment, 9 expressed a CDR 3 of nine 
amino acids or less. Only 4 out of 15 antibody-secreting cells 
used a CDR 3 of nine amino acids or less. The average CDR 
3 length of the germinal center cells was 9.3  _+ 0.26 (_+ SEM, 
n  =  12). X  2 statistical analysis of the distributions of CDR 
3 length across the two populations confirms that a significant 
difference exists  ~  =  0.001). 
The germinal center pathway supports somatic variation 
in the V. genes of antigen-responsive B cells, confirming the 
predictions of MacLennan and Gray (6) and the data from 
more recent studies (11, 12). Furthermore, the majority of 
the earliest products of the germinal center pathway emerge 
initially unmutated, but appear to be a more restricted subset 
of  V,186.2/VLA-bearing  NP-specific  cells  than  their 
antibody-secreting counterparts. These data indicate a branch 
point in antigen-driven B cell development and implicate an- 
tibody fine specificity in the decision to pursue a pathway 
of memory cell differentiation. 
Late Germinal Center Cells Express V,186.2 with a Short 
CDR 3 and Affinity Increasing Mutations.  By day 12 of the 
primary response, many (63%)  NP-specific  cells express a 
V.186.2 gene with numerous somatically introduced muta- 
tions (3.4 per mutated done) (Fig. 8) in agreement with re- 
cent studies on rearranged genomic DNA from animals in 
the primary NP response (22).  Once again, the tyrosine at 
position 95 was conserved in 17 out of 19 cells analyzed. The 
GSS motif at the D-J. border was only expressed in six of 
the cells and N sequence insertions seen in all but four cells, 
displaying a similar level of CDR 3 diversity as seen in the 
previous groups. 
Of the 12 NP-specific cells expressing a mutated receptor, 
11 carried the position 33 tryptophan to leucine change typ- 
ical of the mature NP response (9,  19) and shown to lead 
to a 10-fold increase in a~nity (26). One set of repeat clono- 
types expressing identical CDR 3 (Fig. 8, Nos. 3-5) all con- 
tain the same position 33 change but also carry unique muta- 
tions identifying them as independent cellular events. A silent 
to replacement mutation ratio of 1:9 for the CDRs (1:6 ex- 
pected) and 1:2.7 for the framework regions (1:3.1 expected) 
(24) demonstrates a preferential localization for substitutions 
in the CDR. Further, a 2:8 distribution of silent mutations 
for CDR:framework regions reflects the size of the respec- 
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Figure  7.  Germinal center cells of the early primary response are mostly unmutated. The nucleotide sequence and predicted amino acid assignment 
obtained from individual cells with the phenotype  of antibody-secreting cells or germinal center cells from days 6 and 7 as described. The sequences 
are compared to the germline sequence of V.186.2 displaying only those positions in which changes were seen. Where obtained, sequence to the fourth 
codon in the J. region is displayed and the predicted size of CDR3 is listed in the last column. (Dashes) Identity with the germline sequence, where 
possible J. assignment  is included in the parentheses at the end of each sequence.  (*) DFL16.1  not used. 
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Figure 8.  Mutation and selection in the primary NP response. The nucleotide sequence and predicted amino acid obtained from individual (IgM; 
Mad; GR1)-  IgG1  + NP + X  + cells sorted directly from the spleens of animals 12 d after primary immunization  with NP-KLH. The sequences are 
compared to the germline sequence of V.186.2 displaying only those positions in which changes were seen. Where obtained, sequence to the fourth 
codon in the J. region is displayed and the predicted size of CDR3 is listed in the last column. (Dashes) Identity with the germline sequence, where 
possible J. assignment is included in the parentheses at the end of each sequence. (*) DFL16.1 not used. 
tive area of the V,186.2 gene. Therefore, mutations are ran- 
domly introduced, but clones expressing certain substitutions 
in the CDR (very specifically  a position 33 leucine) are posi- 
tively selected, confirming many studies using both hybrid- 
omas and genomic DNA  (9,  11,  19,  22). 
More interestingly,  10 out of the 12 cells expressing a mu- 
tated Ig also bore a short CDR  3  of nine amino adds or 
less.  These data support the hypothesis  that cells  entering 
the memory cell pathway are selected  initially  for antigen 
binding and a shorter CDR 3 and then later in an iterative 
fashion for af~nity increasing  mutations  (predominantly  a 
change in CDR  1 position  33). 
Discussion 
The Antigen-specific Response to Immunization.  Using six- 
parameter flow cytometry we can directly estimate the numbers 
of splenic B  cells involved in the primary response to NP- 
KLH immunization. We chose to monitor NP-spedfic cells 
that had responded to immunization by switching from IgM 
to IgG1 expression in vivo. The emergence of antigen-specific 
B cells assessed by flow cytometry in the current study corre- 
lates well with many immunohistochemical studies of in vivo 
immune responses (for reviews see references  1,  2, 44--46). 
The lag phase may indicate the time needed for cognate acti- 
vation involving T  and B  cells  in the microenvironmental 
context  of antigen-presenting  cells  in secondary lymphoid 
organs. An extensive proliferative phase soon follows in both 
T  and B cell-rich  areas of these organs with evidence of Ig 
isotype  switch  in both regions  (3). 
During the second week, most of the proliferative activity 
appears localized to the germinal center reaction of secondary 
follicles in the B call zones (6). There appears to be a great 
deal of cell death associated with these structures together 
with the production of long-lived memory B cells (6, 42). 
Evidence for somatic hypermutation (12) and survival of higher 
affinity mutants within the germinal center (11) indicate its 
central role in positive selection and the maturation of affinity 
which is typically associated with T cell-dependent immune 
responses. 
The extent of the isotype-switched NP response observed 
is remarkable,  reaching  an average of 1-2%  of total spleen 
cells during the plateau phase of the second week. These data 
support the extensive immunohistochemical analysis  of the 
response to NP-CG by Jacob et al.  (3).  In situ analysis  by 
this group estimated the B cells in the PALS-associated loci 
to reach 1% of spleen volume at their 8-d peak and '~,300-500 
germinal centers per spleen at their peak by day 12 (55%  of 
which were k + NIP+). Previous flow cytometric analysis of 
an antigen-spedfic response estimated a far lower frequency 
of spedfic  cells  (41,  47).  In those  studies,  the fluorophore 
PE was used as an antigen,  and direct binding on the flow 
cytometer of B220 + (IgM, IgD)-  was used as a criterion of 
a memory cell.  Animals primed 3 mo previously carried  a 
PE-specific memory compartment comprising 0.02-0.05% 
of total spleen cells (47). Even around day 12 of this response, 
frequency estimates were similar and appeared to remain con- 
stant for over the following 200 d (41). These differences from 
the numbers of NP-spedfic cells found in the present study 
may reflect  differences  in the mature of the antigen,  the ex- 
isting T  and/or B cell repertoire,  or the antigen-presenting 
capacity of the system. Furthermore, a kinetic difference  in 
the establishment of the PE response might have contributed 
to  the differences  seen. 
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sessment of individual cells shown to be directly involved in 
the ongoing primary response in vivo. Our approach does 
not suffer the undefined bias introduced by hybridoma fu- 
sion. Furthermore, by using single cells as the starting sub- 
strate and finally direct sequencing of PCR products avoids 
the need for subcloning or screening. This combination of 
processes renders the system operationally free of  background 
and offers a clear view of the onset of somatic mutation to- 
wards the end of the first week after primary challenge. These 
data align well with recent studies on rearranged genomic 
DNA from animals in the primary NP response (22). Studies 
on other hapten responses also describe the appearance of mu- 
tated progeny during the first week (48) or early in the second 
(15). Unlike the response to a T-dependent form of phos- 
phorylcholine,  the NP responders accumulate more muta- 
tions during the second week after immunization, appearing 
more like the response to the hapten 2-phenyl-oxazalone. 
Dual Differentiation Pathways  and Their  Precursors.  We have 
recently described the use of syndecan expression as a defini- 
tive marker of antibody-secreting  cells within the antigen- 
specific compartment in vivo (27). Comparing syndecan ex- 
pression and the binding of the lectin PNA it was possible 
to delineate and quantitate directly the recruitment of antigen- 
specific precursors into the antibody-secreting compartment 
and the germinal center pathway to memory. In both cases, 
the cells expressed  isotype-switched surface  Ig that was capable 
of binding NP. Therefore, the IgM + antibody-secreting cells 
first apparent in the PALS-associated  loci (3) are not included 
in this analysis, nor are the slgM + B cell blasts of the early 
follicular response or the sI~/- centroblasts of the germinal 
center reaction (2). We find that both populations  emerge 
with very similar kinetics. These data suggest that isotype 
switch was coordinated simultaneously in these two pheno- 
typically and functionally  distinct cell compartments. Either 
control for the gene rearrangement event is at a systemic level 
(3), or the initiation of this event occurs at a common time 
point before the functional branching of these two pathways. 
The similar doubling time of NP-specific precursors in the 
proliferative phase of both pathways is close to the more di- 
rect estimations of doubling times for cells in secondary fol- 
licles (6-7 h) (49, 50). The noticeable difference between the 
two populations is seen during the second week after immu- 
nization.  Whereas antibody-seereting  cells decline rapidly, 
the germinal center cell numbers persist at plateau throughout 
the second week. The former parallels the observed life span 
of the PALS-associated  loci cells previously described (3). The 
steady plateau in the latter population suggests that during 
the second week, cell renewal equals cell death in this micro- 
environment. 
Molecular  analyses of single cells from either pathway 
confirms two features of more recent studies. The process 
of somatic mutation proceeds within a germinal center (11, 
12)  and is absent  in the antibody-forming cells of PALS- 
associated loci (12, 26). In the current study, somatic muta- 
tion was seen in the germinal center compartment and not 
in early antibody-secreting  cells. Furthermore, it is evident 
that the early products of the germinal center reaction can 
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switch Ig isotype without evidence of somatic mutation and 
favors independent mechanisms for these two processes. In 
fact, the majority of early germinal center cells were also un- 
mutated. These data support a model in which the germinal 
center environment both initiates the mutational mechanism 
and subsequently selects and expands the desired specificities 
at the cellular level (46). 
The length of the CDR 3 within the germinal center cells 
was significantly shorter than those of the antibody-secreting 
pathway at the end of the first week after challenge. Although 
this feature has been noted in previous studies, it was associated 
with the secondary NP-clonotype in cells already containing 
many mutations and evidence of selection postaffnity matu- 
ration (24). Our data suggests that selection of a shorter CDR 
3 may occur before somatic mutation and that further selec- 
tion occurs after diversification by mutation. It is possible 
that the distinction on CDR 3 length was imposed before 
entry into the memory differentiation pathway, however, it 
is equally likely to be the outcome of an initial round of se- 
lection within the germinal center itself. Indeed, it remains 
to be seen whether this difference is preassorted in the naive 
repertoire as would be predicted by recent studies on the ca- 
pacity of  Jlld  1~ B cells to initiate germinal centers and mem- 
ory responses (51, 52). 
Maturation and Memory Cell Generation.  The sustained 
germinal center pathway dominates the second week of the 
response giving rise to cells bearing the hallmarks of an NP- 
specific memory cell. A  tryptophan to  leucine change at 
position 33 in CDR 1 can by itself lead to a 10-fold affinity 
increase for NP (23). By day 12 of the primary response, the 
majority of cells (63%) in the current study were somati- 
cally mutated. 11 of the 12 mutated clonotypes carried the 
position  33 leucine and 10 of these also expressed a CDR 
3 of nine amino acids in length. These data suggest clones 
selected into the pathway of somatic mutation are further 
selected for the presence of affinity-increasing mutations.  In 
the studies by Weiss et al. (22, 24) by day 10 of the primary, 
8 out of 13 clones carrying a position 33 leucine also had 
a nine-amino acid length CDK 3. By day 14 the frequency 
was 6 out of 6 and by day 42, 11 out of 12 clones also carried 
the shorter CDK. Further, in our previous work on the early 
memory response, >75% of single cells analyzed expressed 
the shorter CDR 3 predominantly associated with the posi- 
tion 33 change to leucine (25). Together, the data support 
the stepwise model of affinity maturation during the primary 
immune response (53-56). 
Conclusions.  The resolution of six-parameter flow cytom- 
etry and the capacity to analyze individual members of rare 
cell populations,  at the molecular and functional level, offer 
unique approaches to the study of  in vivo immune responses. 
The current study further characterizes the development of 
antibody secretion and memory cell generation as indepen- 
dent early outcomes of a primary encounter with antigen. 
The data indicate many branch points in the developmental 
pathway of a primary response B cell and the recruitment 
of a significant number of antigen-specific responders. The 
differences in phenotype, cellular function, and molecular 
mechanisms within antigen-specific cells were divided into two developmental pathways: antibody secretion without so- 
matic mutation as one early response  and germinal center 
formation; somatic mutation and selection of high affinity 
variants into the memory compartment as a second. The events 
that control the outcome of encounter with antigen remain 
elusive. Using our approach, one is able to retrieve antigen- 
specific cells from either pathway at any stage of the ongoing 
response.  The cells are in a normal physiological state and 
can be transferred into appropriate hosts or cultured in vitro 
to reveal their needs for growth and their capacity for dif- 
ferentiation. 
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